CVIR Endovascular (Jim Reekers, Editor-in-Chief)

@cvirendo

CIRSE's open access journal on endovascular treatment. EIC: Academic IR, researcher, IR-trend-watcher. (Profile run by EIC and the Editorial Office)

AMC Amsterdam, Nederland
Vrijeme pridruživanja: ožujak 2017.

Tweetovi

Blokirali ste korisnika/cu @cvirendo

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @cvirendo

  1. Prikvačeni tweet

    To celebrate the success of CVIR Endovascular CIRSE now offers an extra 15% discount on the APC to corresponding authors who are CIRSE members in good standing‼️ To apply for the discount contact the editorial team at info@cvirendovascular.org

    Poništi
  2. Endovascular treatment of angiomyolipoma is the treatment of choice. A combination of ethanol and lipiodol is one of the ways to do this |

    Poništi
  3. 23. sij

    Submit your work to CVIR Endovascular - CIRSE's open access journal and receive a 15% member discount on the article processing charges! Not a CIRSE member yet? Become a CIRSE junior member and enjoy all membership benefits!

    Poništi
  4. Although it is very rare to re-open a common carotid artery, there are some clinical situations where these technologies might be considered. Read more about this:

    Poništi
  5. Great news for German researchers. This deal could be the first important step towards a new scientific publishing landscape in Europe. In this website you can find more details about this agreement.

    Poništi
  6. 17. sij

    Not a bad start for 2020 - a huge topic deserving more attention and publications like these are just the beginning. Thanks for your help

    Poništi
  7. 13. sij

    CIRSE system for classification of COMPLICATIONS in

    Poništi
  8. Professor Pereira talking at the Dutch IR day about how to start an IRO practice.

    Poništi
  9. Dr Jon Bell talking about personalized SIRT. The role of dosimetry.

    Poništi
  10. Dr Mehrzad talking at the Dutch Interventional day (RIDN) about percutaneous transhepatic cholangiograhic endobiliary forceps biopsy.

    Poništi
  11. 15% discount on the publication charges in for all CIRSE members in good standing‼️ Send us an email to get your discount code: info@cvirendovascular.org!

    Poništi
  12. Poništi
  13. 18. pro 2019.

    Join and 1,000+ colleagues at , the premier endovascular meeting taking place Jan. 22-25, 2020 in Hollywood, Florida. Register soon to reserve your spot!

    Poništi
  14. Challenges of new Endovascular technologies are numerous: New European regulations, costs, reimbursement, defining efficacy & replacing established older technologies are just some of the hurdles before a new technique becomes part of our daily IR tool box

    Poništi
  15. 4. pro 2019.

    Women of reproductive age with symptomatic fibroids experience significantly improved quality of life and sexual function, as well as significantly reduced symptoms following treatment with uterine fibroid embolization, a recent study reports

    Poništi
  16. 29. stu 2019.

    Major variations in antiplatelet regimes following lower limb angioplasty. . More great work from

    , , i još njih 7
    Poništi
  17. 27. stu 2019.

    preliminary programme now online. Secure your spot for the congress today and save up to 53%!

    Poništi
  18. Head over to to read their article discussing the launch of the Professor Anna Maria Belli Travelling Grant.

    Poništi
  19. Open access also means open discussion. Have your say & contribute to scientific discussion on endovascular treatments by submitting a Letter to the Editor critiquing a CVIR Endo article. APC waivers available for this article type - contact info@cvirendovascular.org for details!

    Poništi
  20. 24. stu 2019.

    Thank You for the Shout out! will be ready for an incredible Annual Meeting. Appreciate everyone volunteering and coming together to help us push forward! Do not miss Wednesday Plenary Stay Calm and Call IR!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·